AzTrials
AzTrials

Smoking CessationNCT05055778

Establishing the Effectiveness of Publicly Available Smoking Cessation Resource

A study testing SmokefreeTXT in people with Smoking Cessation, run by University of Virginia at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of SmokefreeTXT, a smoking cessation text messaging program currently available to anyone in the United States through www.smokefree.gov, and to compare cessation outcomes for smokers living in different regions of Virginia while participants use the program. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
SmokefreeTXT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteUnited States
Study dates
3 Nov 2021to 6 Feb 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 and over
  • Current cigarette smoker (has smoked at least 100 cigarettes in their lifetime and currently smokes)
  • Ability to read and speak English
  • Resident of Virginia
  • Owns a cell phone

Who cannot join

  • Not a current smoker (e.g., started a quit attempt between providing interest information and starting the study)
  • Identity not able to be verified from information provided on interest form
  • Does not own a cell phone
  • Pregnant smoker or may become pregnant in the next 6 months
  • Lives in an area that has met recruitment criteria (after recruitment has begun)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Virginia

    Charlottesville, Virginia, 22904

Other trials in United States

About this study

Official title: Establishing the Effectiveness of Publicly Available Smoking Cessation Resources: Does Rurality Matter?

The purpose of this study is to evaluate the effectiveness of SmokefreeTXT, a smoking cessation text messaging program currently available to anyone in the United States through www.smokefree.gov, and to compare cessation outcomes for smokers living in different regions of Virginia while participants use the program. Participants will be asked to complete assessments at Baseline, 7 weeks, 3 months, and 6 months and will be asked to use a research version of SmokefreeTXT.

Being tested
SmokefreeTXT
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SmokefreeTXTBehavioural

    The program is identical to the publicly available program available through the National Cancer Institute Smokefree.gov Initiative but has been set up to be delivered through a research account. The program will send 3-5 messages a day over 7 weeks, with one week to prepare for a quit attempt and 6 weeks of cessation support messages. Participants can get real time support for cravings, mood, and slips by texting "keywords" to the program. They keywords are CRAVE, MOOD, and SLIP. Participants can also re-set their quit date by texting NEW. The program asks questions each week to ask about smoking status and about mood and cravings.

Study groups in NCT05055778
Study groupRoleWhat they receive
SmokfreeTXTExperimentalResearch version of the publicly available SmokefreeTXT program
Receives: Behavioral: SmokefreeTXT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported Smoking Cessation

    7-day point prevalence of abstinence (Question wording: Have you smoked a cigarette (even a puff) in the past 7 days? Response options: Yes; No)

    Measured: 7 weeks after study start

  2. Self-reported Smoking Cessation

    7-day point prevalence of abstinence (Question wording: Have you smoked a cigarette (even a puff) in the past 7 days? Response options: Yes; No)

    Measured: 3 months

Secondary outcomes (4)
  1. Self-reported Continuous Abstinence

    Continuous abstinence, 6 weeks after initiating the quit attempt (Question wording: In the last 6 weeks, have you smoked at all? Response options: Yes; No; Not sure)

    Measured: 7 weeks after study start

  2. Self-reported Continuous Abstinence

    Continuous abstinence 3 months after initiating the quit attempt (Question wording: In the last 3 months, have you smoked at all? Response options: Yes; No; Not sure)

    Measured: 3 months

  3. Self-reported Smoking Cessation

    7-day point prevalence of abstinence (Question wording: Have you smoked a cigarette (even a puff) in the past 7 days? Response options: Yes; No)

    Measured: 6 months

  4. Self-reported Continuous Abstinence

    Continuous abstinence 6 months after initiating the quit attempt (Question wording: In the last 6 months, have you smoked at all? Response options: Yes; No; Not sure)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2021
  2. Study start3 Nov 2021
  3. Primary completion6 Feb 2024
  4. Study completion6 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05055778
Sponsor's protocol ID
3928
Status last verified
Feb 2025
First submitted
16 Aug 2021
Last updated
3 Mar 2025
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: If requested, a de-identified dataset will be available to other researchers after the study is completed.

Publications

  • Kinchen JW, Little MA, Ritterband LM, Wiseman KP. Pilot study examining the effect of rurality on engagement and abstinence for adult users of a text-message cessation intervention. BMC Public Health. 2025 Nov 19;25(1):4061. doi: 10.1186/s12889-025-25284-6.

    PubMed 41257752

Questions about this trial

What is this clinical trial studying?

A study testing SmokefreeTXT in people with Smoking Cessation, run by University of Virginia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Mar 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported Smoking Cessation (time frame: 7 weeks after study start). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05055778, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in